Related Experiment Video
Updated: May 22, 2025

An Experimental Platform to Study the Closed-loop Performance of Brain-machine Interfaces
Published on: March 10, 2011
Optimized nonlinear robust controller along with model-parameter estimation for blood glucose regulation in type-1
Atif Rehman1, Syed Hassan Ahmed2, Iftikhar Ahmad2
1School of Interdisciplinary Engineering and Sciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
New adaptive controllers stabilize blood glucose concentration (BGC) in type 1 diabetes. The adaptive backstepping integral super twisting sliding mode control (ABIST-SMC) demonstrated superior efficiency in simulations and hardware tests.
Area of Science:
- Biomedical Engineering
- Control Systems Theory
- Endocrinology
Background:
- Glucose is vital for cellular energy and physiological processes.
- Precise blood glucose concentration (BGC) regulation is critical for health.
- Artificial pancreas systems use control algorithms for BGC management in diabetes.
Purpose of the Study:
- To develop and compare robust nonlinear controllers for stabilizing BGC in type 1 diabetic patients.
- To mitigate disturbances from meals and exercise using adaptive control strategies.
- To enhance health outcomes and quality of life for individuals with type 1 diabetes.
Main Methods:
- Proposed adaptive backstepping sliding mode control (AB-SMC) and adaptive backstepping integral super twisting sliding mode control (ABIST-SMC).
- Compared proposed controllers with backstepping sliding mode control (B-SMC) using the extended Bergman minimal model (EBMM).
- Employed adaptive parameter estimation, improved grey wolf optimization, and Lyapunov control theory for stability analysis.
Main Results:
- ABIST-SMC demonstrated the highest efficiency, achieving target BGC reduction in under 1.92 minutes.
- Proposed controllers showed robust performance and asymptotic stability via Lyapunov analysis.
- Simulations and hardware-in-loop experiments validated controller effectiveness.
Conclusions:
- The developed adaptive controllers offer effective BGC regulation for type 1 diabetes.
- ABIST-SMC presents a promising advancement in artificial pancreas control strategies.
- The study highlights the potential for improved diabetes management through advanced control techniques.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Feedback Loops
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational

